EIB and Germitec sign €25 million financing

The funds will enable Germitec, an innovator in UV-C high level disinfection (HLD) of ultrasound probes, to accelerate the expansion internationally of its devices Chronos® and Antigermix® and support R&D.

“We are thrilled to benefit from the support of the prestigious European Investment Bank. This financing is a strong recognition of the great potential of our UV-C technology. I am confident we will continue to expand our activities Internationally and support healthcare professionals around the world on a daily basis to ensure the safety of their patients during ultrasound examinations.”, said Vincent Gardès, CEO of GERMITEC.

“The EIB is pleased to be contributing to the development of Germitec and its innovative technology to prevent cross infections risks in the disinfection of medical devices. This €25 million financing demonstrates Europe’s focus on supporting innovation and promising technologies in the field of healthcare, an area that is vital for people’s well-being.”, said EIB Vice-President Ambroise Fayolle.